The progressive, involuntary loss of skeletal muscle mass, strength, and function that occurs with advancing age, clinically termed sarcopenia. This condition is a significant contributor to frailty, metabolic dysfunction, and reduced quality of life in older adults. It involves a decline in muscle protein synthesis rates and a shift in the balance between anabolic and catabolic signaling.
Origin
The concept of muscle wasting with age is an observation as old as medicine itself, but the clinical term “sarcopenia” was coined from the Greek words sarx (flesh) and penia (loss or deficiency). It is a central topic in gerontology and endocrinology, directly linked to age-related hormonal decline and cellular senescence.
Mechanism
The underlying mechanism is multifactorial, encompassing reduced responsiveness to anabolic stimuli like resistance exercise and insulin, coupled with a decline in circulating anabolic hormones such as testosterone, growth hormone, and IGF-1. There is an increase in chronic low-grade inflammation, often called inflammaging, which further accelerates muscle protein breakdown. Mitochondrial dysfunction and impaired neuromuscular junction integrity also contribute significantly to the functional decline.
We use cookies to personalize content and marketing, and to analyze our traffic. This helps us maintain the quality of our free resources. manage your preferences below.
Detailed Cookie Preferences
This helps support our free resources through personalized marketing efforts and promotions.
Analytics cookies help us understand how visitors interact with our website, improving user experience and website performance.
Personalization cookies enable us to customize the content and features of our site based on your interactions, offering a more tailored experience.